Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype
暂无分享,去创建一个
W. Weichert | P. Schirmacher | Dagmar Glatz | M. Rehli | J. Gaedcke | W. Dietmaier | Roger Mulet-Lazaro | E. Reuschel | C. Gebhard | Lucia Schwarzfischer-Pfeilschifter
[1] M. Kloor,et al. External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS , 2019, BMC Cancer.
[2] J. Pearson,et al. Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas , 2019, Cellular and molecular gastroenterology and hepatology.
[3] M. Andreu,et al. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy , 2018, PloS one.
[4] M. Urioste,et al. Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system’ , 2018, British Journal of Cancer.
[5] R. Lothe,et al. CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers , 2017, International journal of cancer.
[6] A. Reeve,et al. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer , 2017, BMC Cancer.
[7] M. Toyota,et al. Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators. , 2014, Gastroenterology.
[8] Nita Ahuja,et al. The CpG island methylator phenotype: what's in a name? , 2013, Cancer research.
[9] D. Absher,et al. Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape , 2013, Genome Biology.
[10] G. Meijer,et al. A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] Thomas Lengauer,et al. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues , 2012, Epigenetics.
[12] T. Hagemann,et al. A distinct DNA methylation profile associated with microsatellite and chromosomal stable sporadic colorectal cancers , 2012, International journal of cancer.
[13] B. Misiak,et al. Assessment of chromosomal imbalances in CIMP-high and CIMP-low/CIMP-0 colorectal cancers , 2012, Tumor Biology.
[14] A. Kaneda,et al. Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes , 2010, Cancer science.
[15] Madeeha Kamal,et al. Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy , 2010, Breast Cancer Research.
[16] T. Ushijima,et al. Abstract 176: The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands , 2010 .
[17] C. Benner,et al. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. , 2010, Cancer research.
[18] P. Laird,et al. Analysis of the Association between CIMP and BRAFV600E in Colorectal Cancer by DNA Methylation Profiling , 2009, PloS one.
[19] M. Loda,et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer , 2008, Gut.
[20] D. Notterman,et al. CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal Cancer , 2008, Clinical Cancer Research.
[21] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[22] Michael Rehli,et al. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. , 2006, Cancer research.
[23] M. Loda,et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.
[24] R. Wolff,et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.
[25] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.